ArticleJournal of hepatocellular carcinoma2025

Efficacy and Safety of Ipilimumab Plus Anti-PD-1/PD-L1 Antibodies Combination Therapy in Advanced Hepatocellular Carcinoma Patients Progressing After Multiple Lines of Treatment: A Retrospective Multicenter Study.

Su-Su Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.